January 2017 - Volume 23 - Issue 1

  • Bret A. Lashner, M.D., M.P.H. and Fabio Cominelli, M.D., Ph.D.
  • 1078-0998
  • 1536-4844
  • 12 issues/year
  • 16 out of 78 (Gastroenterology & Hepatology) (2015 JCR)
  • 4.358 (2015 JCR)
Other Supplements

​It is with great enthusiasm that the journal announces Drs. Lashner and Cominelli as the new Co-Editors-in-Chief of Inflammatory Bowel Diseases. Read their first full editorial in the journal where they express their vision in making IBD "the home for the most important research advances, interesting innovations in patient treatment, and resolution of timely controversies.." in the field.

Bret A. Lashner, M.D., M.P.H     Fabio Cominelli, M.D., Ph.D.

Current Issue Highlights

Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers

Herfarth, Hans H.; Jackson, Susan; Schliebe, Barbara G.; More

Inflammatory Bowel Diseases . 23(1):14-22, January 2017.

Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases

Hou, Jason K.; Gasche, Christoph; Drazin, Noam Z.; More

Inflammatory Bowel Diseases . 23(1):35-43, January 2017.

Inflammation and Apoptosis: Dual Mediator Role for Toll-like Receptor 4 in the Development of Necrotizing Enterocolitis

Zhou, Yin; Li, Yibo; Zhou, Bin; More

Inflammatory Bowel Diseases . 23(1):44-56, January 2017.

Letters to the Editor